Akebia Therapeutics
AKBA
AKBA
155 hedge funds and large institutions have $703M invested in Akebia Therapeutics in 2020 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 54 increasing their positions, 42 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 153 → 155 (+2)
0.62% more ownership
Funds ownership: 70.83% → 71.45% (+0.62%)
Holders
155
Holding in Top 10
3
Calls
$10.9M
Puts
$1.4M
Top Buyers
| 1 | +$54M | |
| 2 | +$9.47M | |
| 3 | +$8.61M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.53M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.28M |
Top Sellers
| 1 | -$15.5M | |
| 2 | -$6.14M | |
| 3 | -$5.22M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$4.9M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.91M |